enGene Holdings Inc. announced a private placement to issue up to 20,000,000 common shares at a price of CAD 10 per share for the gross proceeds of up to CAD 200,000,000 on February 14, 2024. The transaction will include participation from new investors such as Adage Capital Management, L.P., Boxer Capital LLC, Commodore Capital, Cormorant Asset Management, LP, Deep Track Capital, LP, Foresite Capital Management, LLC, Janus Henderson Investors, Logos Capital Management, LLC, Marshall Wace LLP, Perceptive Advisors LLC, Soleus Capital, Surveyor Capital Management, Venrock Healthcare Capital Partners, Blue Owl Healthcare Opportunities and a returning investor such as Lumira Ventures and a large investment management firm. The financing is expected to close on February 16, 2024, subject to customary closing conditions.

The securities described above have not been registered under the Securities Act of 1933, as amended.